CatalystWireBeta

Appointment of Chief Financial Officer

In brief · summary, not quotable

Malvern International PLC has announced the appointment of Daniel Chaffer as executive director and CFO Designate, effective June 22, 2026, with a smooth handover from the outgoing CFO, Dan Fisher, expected by September 2026. Chaffer brings over 25 years of financial leadership experience, including serving as CFO for Sentric Music Group, which had £66 million in revenue, and Bioscript Group, where he oversaw revenue growth from £8 million to £28 million. He currently holds no other directorships and no shares or options in the Company.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your MLVN notes

Malvern International plc (AIM: MLVN), the global learning and skills development partner, is pleased to announce the appointment of Daniel Chaffer as an executive director and CFO Designate with effect from 22 June 2026.

Daniel will work closely with the outgoing CFO, Dan Fisher, over the next few months ensuring a smooth and efficient handover. He will assume the role of CFO during the transition period prior to the departure of Dan Fisher in September 2026.

Daniel Chaffer is an experienced CFO and strategic finance leader with over 25 years' experience across professional services, technology, music and the pharmaceutical industries. He is a Fellow of the Institute of Chartered Accountants in England and Wales. Most recently, Daniel served as CFO of Sentric Music Group, a technology-driven music publishing business with £66m revenue, where he led the business through significant organic growth and post-acquisition financial integration. Prior to this he served as CFO of Bioscript Group, a PE-backed medical communications consultancy, overseeing a period of rapid growth from £8m to £28m revenue over a 4-year period, and the successful sale of the business to private equity. Earlier in his career Daniel spent nearly eight years at the BBC as a Finance Business Partner supporting high-profile production and commissioning departments.

Richard Mace, Chief Executive Officer, commented:

"The Board is delighted to have secured someone with Daniel's depth of experience, and to have done so in good time to facilitate an orderly handover at an exciting and busy time for the Group as it looks to build student numbers across its university pathway contracts and summer junior programmes. I would also like to thank Daniel Fisher for his significant contribution to Malvern and for his support in ensuring a smooth transition."

Daniel Chaffer, aged 48, currently holds no other directorships, and holds no ordinary shares or options in the Company.

Current directorshipsPast directorships held within the last five years
NoneSentric Music Ltd Masstrax Music Ltd Sentric Music Group Ltd Black Rock Publishing Ltd IQ Music Ltd Sentric Music Publishing Ltd Cancer Communications Ltd Cancer Communications and Consultancy Ltd Meridian Healthcomms Ltd Meridian Healthcomms Holdings Ltd Portland Medical Communications Ltd Valid Insight Ltd Bioscript Midco 2 Ltd Bioscript Midco 1 Ltd Sapience Medical Education Ltd Fortis Digital Ltd Fortis Pharma Consulting Ltd Azimuth Pharma Ltd Bioscript Holdings Ltd Bioscript Ltd

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note